Abstract
BackgroundPatients with Type 2 Diabetes Mellitus (T2DM) are at a relatively higher risk of severe stroke. Glucagon like peptide-1 receptor agonists (GLP-1RAs) are licensed for the management of T2DM. Cardio-...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have